(Q42407837)

29 October 2017

Ethical responsibility of phase 0 trials (English)

1 reference

29 October 2017

Roberto Jun Arai

1

1 reference

29 October 2017

Paulo Marcelo Gehm Hoff

series ordinal

2

1 reference

29 October 2017

Gilberto de Castro

series ordinal

3

1 reference

29 October 2017

Arnold Stern

series ordinal

4

1 reference

29 October 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

29 October 2017

Clinical Cancer Research

1 reference

29 October 2017

15

1 reference

29 October 2017

3

1 reference

29 October 2017

1121; author reply 1121-2

1 reference

Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice

29 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957892

PubMed Central

reference URL

Compressing drug development timelines in oncology using phase '0' trials.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957892

PubMed Central

reference URL

What's the price of a research subject? Approaches to payment for research participation.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957892

PubMed Central

reference URL

10.1158/1078-0432.CCR-08-1824

16 August 2018

Identifiers

DOI

1 reference

29 October 2017

1 reference

29 October 2017

PubMed publication ID

19188189

1 reference